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Abstract
Background: Depression and bipolar illness are associated with a 2–3 fold
increase in the prevalence of diabetes. However, it is unknown whether variation in
mood affects glucose metabolism. The aim of this study was to assess whether
changes in affect were related to fasting plasma glucose and glycated haemoglobin.
Methods: 379 men and 441 women who took part in the 2003 Health Survey for
England and had valid data for GHQ12 and fasting blood glucose were included.
Mood variability was assessed by the General Health Questionnaire 12 (GHQ12).
Fasting plasma glucose and glycated haemoglobin (HbA1c) were measured by
standard laboratory methodology and their relationship to variability assessed
using linear regression.
Results: There was a significant inverse relationship between fasting blood
glucose, but not HbA1c, and variability score (R
2 = 0.327, p = 0.02) after adjusting
for sociodemographic factors, anthropometric measurements, lifestyle, and use of
medication.
Conclusion: This study has shown an inverse association between changes in
affect and fasting plasma glucose. This unexpected finding suggests that the
association between affect and glucose is more complex than previously thought.
Fasting blood glucose may reflect the operation of homeostatic mechanisms that
are disturbed in certain mental states and are associated, therefore, with altered risk
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of diabetes and related metabolic conditions. This may have implications for the
management of those with such conditions and with mental disorders.
Keywords: Medicine
1. Introduction
The prevalence of depression and depressive symptoms is approximately two-fold
higher in people with diabetes while epidemiological studies have demonstrated
that this association is bi-directional (Holt et al., 2014). A meta-analysis of 11
studies found that adults with depression had a 37% increased risk of developing
type 2 diabetes (Knol et al., 2006) while two further meta-analyses indicated that
incident depression was increased by 15–24% in people with diabetes (Mezuk
et al., 2008; Nouwen et al., 2010). The mechanisms and pathogenesis underlying
the association are unclear but a variety of explanatory theoretical models have
been proposed, including a psychological response to the diagnosis and treatment
demands, common biological and environmental pathways and possible treatment
effects.
Variability of mood which leads to mood instability (“lability”) is an important and
clinically significant symptom (Marwaha et al., 2013). For example, studies
suggest that there is greater positive affect during the day and greater diurnal mood
variation in negative affect in people with major depression compared to matched
controls (Marwaha et al., 2013). Mood instability, when assessed by the question
“Do you have a lot of sudden mood changes?”, increased the odds of experiencing
non-psychotic symptoms by nearly 10 fold (Marwaha et al., 2013). Lability or
mood instability is also associated with a number of psychiatric conditions
including attention deficit disorders (Stringaris and Goodman, 2008; Marwaha
et al., 2013), borderline personality disorder and bipolar disorder (Marwaha et al.,
2014), and major depression (Marwaha et al., 2013).
Few studies have examined variability of mood in relation to glucose metabolism.
Kotani et al. (2007) found a significant positive relationship between “mood
change tendency” and fasting blood glucose in a group of healthy people. Skaff
et al. (2009) looked at the daily emotional “ups and downs” in a group of
participants with type 2 diabetes. After adjusting for sociodemographic
characteristics, BMI, time with diabetes, medicines and indices of depression,
they found that, in men, when negative affect was greater than the individual’s own
average level on one day, the fasting glucose was higher than the mean value the
next morning.
The aim of the present study was to examine the relationship between mood
variability, assessed using the GHQ12 (Goldberg and Williams, 1988), and fasting
blood glucose in a general population sample in which it was possible to control for
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potential confounders. As mood variability predisposes to depression and a number
of other psychiatric illnesses which are associated with increased rates of diabetes,
we hypothesised that mood variability would be associated with increased glucose
concentration.
2. Method
2.1. Participants
The Health Survey for England is a national survey carried out each year on a fresh
sample of the population of England living in private households. The sample is
chosen using a stratified, random sampling technique and is representative of the
population from which it is drawn. Since 1993 it has included participants aged 2
years upwards, and in 2003 there were 14,836 participants who were aged 16 or
over (mean age 46 yrs: see Table 1). 6602 were men and 8234 were women.
Ethical approval for the Survey was granted by the London Multi-Centre Research
Ethics Committee (MREC) and informed consent obtained from all participants,
which in the case of blood samples was in writing (Sproston and Primatesta, 2004).
2.2. Measures
The 2003 Survey focused on cardiovascular disease and its risk factors, and
included the General Health Questionnaire (GHQ12) as well as questions on
smoking, alcohol intake, diet and physical activity, relevant medical history and
medication (Sproston and Primatesta, 2004). The questionnaires, including the
GHQ12, were administered during an initial interview.
2.2.1. Lifestyle questions
Alcohol consumption was assessed by answers to the question “Whether drinks
nowadays”, smoking by answers to the question “Whether smokes cigarettes
nowadays”, dietary salt intake by answers to the question “Salt added when
cooking?” and consumption of cakes, chocolates, crisps, nuts or biscuits by
answers to questions “How often eat cakes?” and “How often eat chocolate, crisps
or biscuits?”.
Fruit and vegetable intake was assessed by portions of fruit (including orange
juice) and vegetables yesterday. Physical activity level was coded as low, medium
or high depending on the responses to questions about specific forms of physical
activity-including sports, walking, manual work, and housework.
2.2.2. GHQ12 questionnaire
The GHQ12 questionnaire was completed by all those aged 13 years and above.
The GHQ12 is intended to detect possible mental illness in the general population
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Table 1. Comparing gender, age and prevalence of doctor-diagnosed diabetes amongst those with valid values of fasting glucose, HbA1c and variability of
mood with the total sample aged 35 (or 16) and over in the 2003 Health Survey for England.
35 and over with valid values for GHQ12 and fasting glucose All 35 and over 16 and over with valid values for GHQ12 and HbA1c All 16 and over
% Males 46% 44% 46% 45%
Mean age 55 yrs 56 yrs 49 yrs 49 yrs
% with doctor-diagnosed diabetes 3.0% 5.4% 3.4% 4.1%
n 820 10,890 7872 14,836
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(Goldberg and Williams, 1988), and within community or non-psychiatric clinical
settings such as primary care or general medical out-patients.
There are six “negative” questions with responses ranging from “Not at all”, “No
more than usual;” “Rather more than usual” to “Much more than usual”. The
GHQ12 also includes “positive” questions, with possible responses including
“Better than usual”, “Same as usual”, “Less than usual”, and “Much less than
usual”. In conventional scoring methods, the first two answers to positive questions
are usually collapsed so that improvements in positive affect do not contribute to
the score (cf. Huppert and Whittington, 2003; Ploubidis et al., 2007).
The GHQ was originally developed on the premise that it focused on breaks in
normal function rather than on lifetime traits and therefore may underestimate the
prevalence of chronic illness (Goodchild and Duncan-Jones, 1985). We used the
measures of change in normal function to our advantage. In order to assess
variability in mood, any participant who responded “Rather more than usual” or
“Much more than usual” to one of the negative items received a score of “1” for
that question. If they responded “Better than usual”, “Less than usual”, or “Much
less than usual” to one of the positive questions they received a score of 1 for that
question.
We considered using a scale of 0, 1 and 2 to differentiate the size of the change but
this would have incorrectly implied that the categories were equidistant from one
another (e.g. that the difference between “Rather more than usual” and “Much
more than usual” was the same as that between “Rather more than usual” and “No
more than usual”), and so we chose a simple bimodal scale of 0 or 1 instead.
Scores thus reflected change whether in response to a negative question or a
positive one, and in the case of the latter regardless of whether it represented an
increase or a decrease of positive affect. The total change score was defined as
“variability” and any participant could obtain a score of between 0 and 12.
2.2.3. Anthropometry and blood test
A number of anthropometric measurements were also taken, including weight,
height and waist and hip circumference to calculate the waist-hip ratio.
A blood sample for HbA1c was obtained from those aged 16 years or above at a
second, nurse visit. A fasting blood glucose sample was also taken in those aged 35
years or above by a nurse. The average interval between the interviewer visit, at
which the self-completion booklet containing the GHQ12 was administered, and
the nurse visit at which the fasting blood sample was taken was 31 ± 24 days.
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2.3. Statistics
Data are reported as mean ± SD. The data were analysed with IBM SPSS Statistics
19 using a linear regression analysis in which fasting plasma glucose was the
dependent variable and variability of mood the independent variable. The
regression was then repeated with the following additional variables included as
covariates:
• Age
• Gender
• Medication for central nervous system (CNS), cardiovascular or endocrine
disease
• Alcohol
• Smoking
• Diet
○ Addition of salt to cooking
○ Consumption of cakes, chocolate, crisps, nuts or biscuits
○ Fruit and vegetables intake
○ Fat intake
• Physical activity
• Waist-hip ratio
• Doctor diagnosed diabetes (excluding gestational diabetes)
A separate regression analysis was carried out with mood variability as the
independent variable and HbA1c as the dependent variable, restricting the analysis
to those aged 16 or over as HbA1c was only carried out on those in this age range.
3. Results
3.1. Participant characteristics
854 participants had valid fasting blood glucose measurements (5.2 ± 1.0 mmol/L
range: 3.0–17.5 mmol/L). 14,490 participants had valid values for mood variability
(1.7 ± 2.5, range 0–12).
There were 379 men and 441 women for whom data were available for both
GHQ12 and fasting blood glucose (Age: 55.1 ± 13.0 yrs; range: 35–89). Table 1
below compares this sample with the overall sample of those aged 35 or over in the
2003 Health Survey.
8199 participants had valid HbA1c measurements (mean ± SD = 5.3% ± 0.7%; 34
mmol/mol. ± 8 mmol/mol). 3614 men and 4258 women had valid values for both
GHQ12 and HbA1c (Age: 49.25 ±17.1 yrs; range:16–98).
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Table 1 shows how this sample compares with the overall sample of those aged 16
or over in the 2003 Health Survey.
3.2. Relationship between fasting glucose, HbA1c and variability
score
There was a significant inverse relationship between fasting blood glucose and
variability score (p = 0.013; t = −2.477; R = 0.086; R square = 0.007) in the
bivariate analysis.
In the multivariate analysis, age and a diagnosis of diabetes were significantly
related to fasting glucose (age: p = 0.001; doctor diagnosed diabetes: p < 0.001).
The association between mood variability and fasting glucose remained after
adjustment for all covariates (p = 0.02; R square = 0.327) (Table 2).
By contrast there was no significant association between variability of mood and
HbA1c.
Table 2. Ordinary least squares (OLS) regression of fasting blood glucose on
mood variability and potential confounders (* p < 0.05; ** p < 0.01).
Explanatory variables Coefficients Standard
errors
Mood variability -0.033* 0.014
Age 0.011** 0.003
Gender 0.100 0.093
Taking CNS medicine -0.075 0.098
Taking cardiovascular medicine 0.110 0.092
Taking endocrine medicine -0.007 0.114
Doctor diagnosed diabetes -2.329** 0.211
Drink alcohol -0.220 0.118
Current smoker -0.010 0.082
Salt added in cooking -0.020 0.069
Cakes often eaten 0.061 0.040
Chocolate, crisps, nuts or biscuits often eaten 0.017 0.039
Portions of fruit and vegetables eaten the previous day 0.003 0.016
Fat intake score 0.008 0.005
Physical activity level -0.002 0.046
Waist/hip ratio 1.088 0.570
Constant 7.854 0.818
Adjusted r2 0.306
F(16,503) 15.277**
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4. Discussion
Although set up primarily to monitor the health of the country (Gupta, 1994), the
Health Survey for England also has considerable potential to be used as a research
tool. This afforded us the opportunity to examine a general population sample,
representative of those living in private households in England in 2003. Amongst
this group, contrary to our initial hypothesis, there was a significant inverse
relationship between mood change scores (variability) and subsequent fasting
blood glucose. By contrast, there was no relationship between variability and
HbA1c which reflects the average plasma glucose concentration over a longer
period of 6–8 weeks, as opposed to fasting glucose, which largely reflects hepatic
glucose output.
Variability of mood to a degree that leads to mood instability (“lability”) is an
important and common clinically significant symptom. The present study used the
12 item GHQ12 questionnaire which has been shown to be valid and reliable in
many different countries and cultures (e.g. see Piccinelli et al., 1993). The scoring
method used in this study has not, to our knowledge, been used in this way before
but the method has face and construct validity. However, further research will be
needed to determine whether mood variability as assessed in this way is a stable,
enduring trait, and also to replicate the findings of the present study.
In the light of the associations between type 2 diabetes and psychiatric disorder, we
had hypothesised that increased variability of mood (which may be a marker of
increased emotional/behavioural reactivity and a predictor of psychiatric illness)
would be associated with increased fasting plasma glucose. We were therefore
surprised to find the opposite. However, this finding is not unprecedented. For
example, a US study (Golden et al., 2008) found evidence that obesity and insulin
resistance might be associated with a lower risk of developing depression and they
confirmed that individuals with impaired fasting glucose had a reduced risk of
incident depressive symptoms. On the other hand, a later paper from the Whitehall
Study (Kivimaki et al., 2009) found a U-shaped association between fasting
glucose and depression with the lowest depression risk seen among those in the
normoglycemic range of HbA1c.
Possible explanations for the observed paradoxical inverse association between
variability of mood and diabetes risk emerge when one considers the literature on
atypical depression. People with bipolar disorder show greater short-term mood
fluctuations when depressed than people with unipolar depression (e.g. Aheam and
Carroll, 1996), while nearly three quarters of people with atypical major depression
meet the criteria for bipolar disorders (Perugi et al., 1998). Thus, atypical depression
appears to be associated with more labile and reactive mood. Atypical depression is
associated with hypoactivity of the hypothalamic-pituitary-adrenal (HPA) axis, low
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cortisol concentration, less CRF, and reduced activation of noradrenergic pathways
(Juruena and Cleare 2007; Lamers et al., 2013).
Another study of glucose disposal in depression showed that people with atypical
depression had lower sympathoadrenal responses and higher insulin concentrations
than healthy controls (Schweiger et al., 2008). Reduced sympathetic nervous
system responsiveness and hyperinsulinaemia could lead to lower fasting blood
glucose levels. Schweiger et al. (2008) suggest that overeating (a feature of
atypical depression) may be a way of maintaining an adequate supply of glucose to
the brain and that changes in eating behaviour in depression are secondary to
alterations in brain glucose metabolism and glucose allocation. This has been
found to be associated with abnormalities of cortisol regulation at certain points of
the day (Thorn et al., 2011), and the diurnal physiology and metabolism of both
blood pressure and blood glucose are known to be under the influence of circadian
clocks (Singh et al., 2016).
Lability of mood may reflect the emotional reactivity of the individual to
psychosocial stress. It has features in common with atypical depression and it is
possible that it may also be associated with reduced activity of the HPA axis and/or
of noradrenergic pathways. These in turn are involved in homeostatic mechanisms
which come into operation in the fasting state in response to physiological stress.
Insensitivity of such biological mechanisms could lead to lower levels of fasting
glucose and hence explain the inverse relationship between the latter and
variability of mood. HbA1c, on the other hand, reflects average plasma glucose
concentration over a longer period, rather than the short term response to the
withdrawal of food, and this may explain why there is no association with
variability of mood.
The present study does not permit conclusions about the direction of any causative
pathway between mood variability and low fasting glucose. Nevertheless, it is
interesting that Yehuda et al. (1990) found that the mean cortisol level in a post-
traumatic stress disorder group was significantly lower, and the range narrower,
than that observed in healthy volunteers (cf. Meewisse et al., 2007). They suggest
that this is due to physiological adaptation of the hypothalamic-pituitary-adrenal
axis to chronic stress. It is possible, therefore, that increased emotional reactivity
results in repeated activation of the HPA axis and the sympathetic nervous system
which eventually leads to a state of physiological decompensation. The related
atypical depression may be initially associated with lower levels of fasting glucose,
but hyperphagia, inactivity and possibly reduced cortisol may over time lead to
increased BMI, waist–hip ratio and inflammation (Lamers et al., 2013), which in
turn could result in insulin resistance and type 2 diabetes. Thus, whilst elevated
levels of catecholamines and cortisol may cause damage to the cardio- and
Article No~e00160
9 http://dx.doi.org/10.1016/j.heliyon.2016.e00160
2405-8440/© 2016 Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
cerebro-vascular system (Singh et al., 2012), abnormally low levels may also have
pathological effects in the long term.
There are a number of limitations to the study. In the interests of confidentiality,
the GHQ is self-administered rather than by a trained interviewer, and does not
specifically ask about mood, though many of the questions are related to mood and
we used it as a proxy measure of mood variability. The association between the
latter and fasting glucose is small in real terms (and based on low numbers
compared with those for HbA1c). This may be because a general population sample
was used, and a stronger relationship might emerge in clinical populations (with
the caveat, that the relationships in clinical populations may not necessarily be the
same as in non-clinical ones). The relationship is cross-sectional. Longitudinal
studies could clarify the relationship. A further limitation is that fasting glucose
was not measured at the same time as mood variability; however, this might also be
considered a strength because it suggests that the relationship may not simply
result from the direct impact of low glucose on mood (or vice versa), but rather
both may be due to common underlying mechanisms. Glucose was measured at
just one point in time when in fact there is also evidence for disorders which relate
to the extent of variability of glucose (Singh et al., 2014). Some of the covariates
(e.g. dietary measures) were based on self-report and it is conceivable, therefore,
that they, or other variables, may have produced residual confounding of the
results.
5. Conclusions
There is evidence from this study that variability of mood is associated with lower
fasting glucose. There is considerable evidence for an association of psychiatric
morbidity and metabolic disorders, and the results of this study may shed light on
the relationship between them, and the mechanisms underlying these associations.
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